Collexis' Expert Profiling for the UK's Biomedical Research Community

Collexis Holdings, Inc.A new agreement was announced between Collexis Holdings Inc. (OTCBB: CLXS), a leading developer of semantic knowledge discovery software and expert profiles, and JISC Collections for an online resource, which aims to encourage greater collaboration and expand scientific knowledge amongst the biomedical research community in the UK. For specially negotiated subscription fees, researchers, teaching staff and students at universities and research councils in the UK, will be able to access Collexis' Expert Profiling. This online resource enables users to quickly identify experts within their institution as well as identify, locate and collaborate with other experts from around the world.

Using the Collexis system, subscribing institutions can create expert profiles of investigators, researchers and departments to disseminate ground-breaking research and biomedical advances. These profiles are generated using researchers’ publications from a variety of sources. Profiles are then available to all researchers, allowing them to easily find what is being published, what researchers are active and the pace of research in a particular area of interest.

"Collexis' Expert Profiling System fosters collaboration among researchers, allowing them to leverage the information of their colleagues and work to enhance, stimulate and create new ideas and discoveries," said Bill Kirkland, CEO of Collexis Holdings, Inc. "We are excited about working with JISC Collections to create internal expert profiling systems that bridge the gap between departments, cooperating organisations, basic research and clinical research."

Lorraine Estelle, CEO of JISC Collections, says that this agreement will "save users researchers time identifying expertise within their institutions, but provides opportunities for research and help widen access to essential sources of biomedical research. We also hope that it will encourage greater collaboration across our community through increased awareness and through the sharing of research outputs amongst institutions."

In addition to the new agreement with JISC Collections, Collexis Holdings Inc. is bringing its innovative technology to other research organisations and universities worldwide, including the Mayo Clinic Libraries; Johns Hopkins University; Dana-Farber Cancer Institute, the University of California, San Francisco; the University of South Carolina; Bristol-Myers Squibb; Lockheed Martin; World Health Organization, National Institutes of Health; and U.S. Department of Defense.

Collexis' Expert Profiling is available to all staff and students within a subscribing university or research council institution in the UK. Institutions wanting access to the service will be required to pay an annual subscription fee. For further information, please go to: http://www.jisccollections. ac.uk/catalogue/collexis_expert.

Related news articles:

About Collexis Holdings, Inc.
Collexis Holdings, Inc., a leading developer of semantic search and knowledge discovery software is headquartered in Columbia, South Carolina (USA) with major operations in Cincinnati, Ohio, Geldermalsen, the Netherlands and Cologne, Germany. Collexis now offers the world’s first pre-populated scientific social network for life science researchers, www.biomedexperts.com. Collexis' proprietary technology builds conceptual profiles of text, called Fingerprints, from documents, Websites, emails and other digitized content and matches them with a comprehensive list of pre-defined “fingerprinted” concepts to make research results more relevant and efficient. This matching of concepts eliminates the ambiguity and lack of priority associated with word searches. The results are often described as "finding needles in many haystacks". Through this novel approach, Collexis can build unique applications to search, index and aggregate information as well as prioritize, trend and predict data based on sources in multiple industries without the limitations of language or dialect. Collexis' current clients in the public, private and academic sectors include the Mayo Clinic; Johns Hopkins University; Dana-Farber Cancer Institute, the University of California, San Francisco; the University of South Carolina; Erasmus University Library; Bristol-Myers Squibb; Lockheed Martin; the World Health Organization; Wellcome Trust; the National Institutes of Health; and the U.S. Department of Defense. Shares of Collexis common stock are traded under the symbol CLXS on the OTC Bulletin Board (OTC BB). For more information, visit www.collexis.com.

About JISC Collections
JISC Collections was established as a mutual trading company by the UK further and higher education funding councils in 2006 to negotiate with publishers of online information and other owners of digital content. The range of resources licensed for use by such agreements constitutes a large national collection of online resources for education and research. JISC Collections is funded by JISC. For further information, please go to http://www.jisc-collections.ac.uk.

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...